Mutation Analysis for TP53 in Chronic-Type Adult T-Cell Leukemia/Lymphoma

作者: Noriaki Yoshida , Yoshitaka Imaizumi , Atae Utsunomiya , Hiroaki Miyoshi , Fumiko Arakawa

DOI: 10.3960/JSLRT.55.13

关键词: CD58Cancer researchCell cycleCDKN2ALymphomaLeukemiaNeoplasmComparative genomic hybridizationAdult T-cell leukemia/lymphomaBiology

摘要: Adult T-cell leukemia/lymphoma (ATLL) is a neoplasm caused by human leukemia virus type I (HTLV-I). ATLL classified into four clinical subtypes based on the manifestation: acute, lymphoma, chronic and smoldering. Approximately half of cases progressed to acute type. We previously demonstrated that genomic alterations related cell cycle de-regulation such as CDKN2A immune escape CD58 alteration can serve predictive biomarkers for transformation Although TP53, which known be major regulator cycle, has been identified in several types cancers including ATLL, no copy number TP53 was found array comparative hybridization. In present study, mutation further analyzed sequencing these well HTLV-I carriers with oligo-clonality. However, identified. These results suggested plays role later stage development.

参考文章(24)
A Sakashita, T Hattori, CW Miller, H Suzushima, N Asou, K Takatsuki, HP Koeffler, Mutations of the p53 gene in adult T-cell leukemia. Blood. ,vol. 79, pp. 477- 480 ,(1992) , 10.1182/BLOOD.V79.2.477.477
Masao Tomonaga, Yoichi Hirakata, Shimeru Kamihira, Masayuki Tawara, Simon J. Hogerzeil, Yasuaki Yamada, Yumi Takasaki, Hiroshi Soda, Hiroo Hasegawa, Ken Murata, Shuichi Ikeda, Yoshitaka Imaizumi, Kazuyuki Sugahara, Kazuto Tsuruda, Kunihiro Tsukasaki, Impact of p53 aberration on the progression of Adult T-cell Leukemia/Lymphoma. Cancer Letters. ,vol. 234, pp. 249- 255 ,(2006) , 10.1016/J.CANLET.2005.03.039
Audrey Petitjean, Ewy Mathe, Shunsuke Kato, Chikashi Ishioka, Sean V. Tavtigian, Pierre Hainaut, Magali Olivier, Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Human Mutation. ,vol. 28, pp. 622- 629 ,(2007) , 10.1002/HUMU.20495
Yumi Takasaki, Masako Iwanaga, Yoshitaka Imaizumi, Masayuki Tawara, Tatsuro Joh, Tomoko Kohno, Yasuaki Yamada, Shimeru Kamihira, Schuichi Ikeda, Yasushi Miyazaki, Masao Tomonaga, Kunihiro Tsukasaki, Long-term study of indolent adult T-cell leukemia-lymphoma Blood. ,vol. 115, pp. 4337- 4343 ,(2007) , 10.1182/BLOOD-2009-09-242347
Makoto Yamagishi, Kazumi Nakano, Ariko Miyake, Tadanori Yamochi, Yayoi Kagami, Akihisa Tsutsumi, Yuka Matsuda, Aiko Sato-Otsubo, Satsuki Muto, Atae Utsunomiya, Kazunari Yamaguchi, Kaoru Uchimaru, Seishi Ogawa, Toshiki Watanabe, Polycomb-Mediated Loss of miR-31 Activates NIK-Dependent NF-κB Pathway in Adult T Cell Leukemia and Other Cancers Cancer Cell. ,vol. 21, pp. 121- 135 ,(2012) , 10.1016/J.CCR.2011.12.015
Davide Rossi, Hossein Khiabanian, Valeria Spina, Carmela Ciardullo, Alessio Bruscaggin, Rosella Famà, Silvia Rasi, Sara Monti, Clara Deambrogi, Lorenzo De Paoli, Jiguang Wang, Valter Gattei, Anna Guarini, Robin Foà, Raul Rabadan, Gianluca Gaidano, Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia Blood. ,vol. 123, pp. 2139- 2147 ,(2013) , 10.1182/BLOOD-2013-11-539726
Richard F Edlich, Jarrett A Arnette, Freddie M Williams, Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). Journal of Emergency Medicine. ,vol. 18, pp. 109- 119 ,(2000) , 10.1016/S0736-4679(99)00173-0
Koichi Ohshima, Yasuo Mukai, Hiroshi Shiraki, Junji Suzumiya, Koutaro Tashiro, Masahiro Kikuchi, Clonal integration and expression of human T-cell lymphotropic virus type I in carriers detected by polymerase chain reaction and inverse PCR American Journal of Hematology. ,vol. 54, pp. 306- 312 ,(1997) , 10.1002/(SICI)1096-8652(199704)54:4<306::AID-AJH8>3.0.CO;2-Z
Thierry Soussi, Christophe Béroud, Assessing TP53 status in human tumours to evaluate clinical outcome. Nature Reviews Cancer. ,vol. 1, pp. 233- 239 ,(2001) , 10.1038/35106009